Beyond the Headlines: What the FDA Decisions on Extended-release and Long-Acting Opioids Mean for People With Pain

by admin on September 17, 2013

CHICAGO, Sept. 17, 2013 /PRNewswire-USNewswire/ – The physicians of the American Academy of Pain Medicine (AAPM) hailed long-awaited labeling changes and other steps taken by the U.S. Food and Drug Administration (FDA) last week to enhance safety in the prescribing of extended-release and long-acting (ER/LA) opioids. AAPM further supported the Agency's decision to deny portions of a citizen …

View full post on pain – Yahoo! News Search Results

Previous post:

Next post: